Filter by: patients
Home > Community Treatment Reports and Side Effects > Interleukin-2 Treatment Report
What is Interleukin-2?

Interleukin-2 and IL-2 are other names for Aldesleukin. Proleukin is the trade name for Interleukin-2. It is an antineoplastic agent, used for the treatment of metastatic renal cell cancer, metastatic melanoma.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
ALS (Amyotrophic Lateral Sclerosis) 1 1 Efficacy_none
HIV (Human Immunodeficiency Virus) 1 0
Melanoma 1 0

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 0
Moderate
 0
Mild
 0
None
 1

Reported Stop Reasons

Why Patients Stopped Using Interleukin-2 (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work 1   Did not seem to work: 33%
Doctor's advice 1   Doctor's advice: 33%
Course of treatment ended 1   Course of treatment ended: 33%

See all 3 patients who’ve stopped using Interleukin-2

Reported Duration See details about how long patients take this treatment ▼

Stopped Using Interleukin-2

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Interleukin-2

Always
 1 100%
Usually
 0 0%
Sometimes
 0 0%
Never
 0 0%

Burden

Difficulty being on treatment

Burden of Interleukin-2

Very
 0 0%
Somewhat
 1 100%
A little
 0 0%
Not at all
 0 0%

Cost

Paid out of pocket

Cost of Interleukin-2

$200+
 0 0%
$100-199
 0 0%
$50-99
 0 0%
$25-49
 0 0%
< $25
 0 0%

Report created on May 28, 2012.